ENTITY
HeMo Bioengineering

HeMo Bioengineering (HMB HK)

4
Analysis
Health Care • Hong Kong

bullish•HeMo Bioengineering
•02 Feb 2022 09:14

Pre-IPO HeMo Bioengineering - Insights on Industry, Business and Concerns

We analyzed the industry characteristics, the business and competitive landscape of HeMo. The centralized procurement, commercialization...

Logo
399 Views
Share
•30 Dec 2021 09:15

Concerns and Outlook on China Neuro-Interventional Industry

The insight analyzed ChinaĀ neuro-interventionalĀ industry including the reason of cool-down in primary market, theĀ product homogenization, fierce...

Logo
608 Views
Share
bullish•Li Ning
•31 Oct 2021 09:56

ECM Weekly (31st October 2021) - Patym, PolicyBazaar, Nykaa, HeMo, Clover Bio, UJU, Airdoc, Mitratel

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Logo
326 Views
Share
bearish•HeMo Bioengineering
•28 Oct 2021 14:47

HeMo Bioengineering (ē¦¾ęœØē”Ÿē‰©å·„ēØ‹) Pre-IPO: Signs of Lacking Innovation

We look at HeMo Bioengineering's main products. We are not convinced that its aspiration catheter products are innovative and competitive.

Logo
614 Views
Share
x